Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CALL
TherapeuticsMD
TXMD
$26.4M
| $866K | ﹤0.01% |
3,000
-1,000
| -25% | -$310K |
|
|
DD
2327
DELISTED
Du Pont De Nemours E I
DD
| $866K | ﹤0.01% |
11,792
-10,835
| -48% | -$770K |
|
|
CTB
2328
DELISTED
Cooper Tire & Rubber Co.
CTB
| $865K | ﹤0.01% |
22,274
-327,294
| -94% | -$12.3M |
|
|
HTZ
2329
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $862K | ﹤0.01% |
46,040
| – | – |
|
|
ENOC
2330
DELISTED
EnerNOC, Inc.
ENOC
| $860K | ﹤0.01% |
+143,405
| New | +$831K |
|
|
GK
2331
DELISTED
G&K Services Inc
GK
| $859K | ﹤0.01% |
+8,908
| New | +$852K |
|
2332
Harte-Hanks
HHS
$31.8M
| $856K | ﹤0.01% |
56,662
+41,308
| +269% | +$626K |
|
2333
Virtus Investment Partners
VRTS
$1.12B
| $856K | ﹤0.01% |
7,248
+3,468
| +92% | +$379K |
|
2334
Avis
CAR
$5.09B
| $855K | ﹤0.01% |
+23,320
| New | +$844K |
|
|
INOV
2335
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $852K | ﹤0.01% |
+82,757
| New | +$1.13M |
|
|
FLXN
2336
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $852K | ﹤0.01% |
+44,804
| New | +$856K |
|
|
RGLS
2337
DELISTED
Regulus Therapeutics
RGLS
| $847K | ﹤0.01% |
3,135
+2,750
| +714% | +$894K |
|
2338
RBC Bearings
RBC
$16.3B
| $845K | ﹤0.01% |
9,108
+3,376
| +59% | +$272K |
|
|
EVRI
2339
DELISTED
Everi Holdings
EVRI
| $844K | ﹤0.01% |
389,037
-27,628
| -7% | -$64.1K |
|
|
XTLY
2340
DELISTED
Xactly Corporation
XTLY
| $843K | ﹤0.01% |
76,673
-54,115
| -41% | -$706K |
|
2341
Corvus Pharmaceuticals
CRVS
$1.24B
| $842K | ﹤0.01% |
58,887
-51,167
| -46% | -$778K |
|
2342
iShares Gold Trust
IAU
$68.1B
| $842K | ﹤0.01% |
+37,999
| New | +$891K |
|
2343
First Internet Bancorp
INBK
$239M
| $841K | ﹤0.01% |
+26,276
| New | +$716K |
|
|
NRE
2344
DELISTED
NorthStar Realty Europe Corp.
NRE
| $837K | ﹤0.01% |
66,576
+46,282
| +228% | +$507K |
|
2345
Schwab US Large- Cap ETF
SCHX
$74B
| $833K | ﹤0.01% |
93,798
-116,772
| -55% | -$1.01M |
|
2346
ImmunityBio
IBRX
$8.74B
| $832K | ﹤0.01% |
+145,407
| New | +$970K |
|
|
FIT
2347
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $832K | ﹤0.01% |
113,604
+47,072
| +71% | +$482K |
|
2348
Fortress Biotech
FBIO
$93.7M
| $829K | ﹤0.01% |
+20,464
| New | +$765K |
|
|
MJCO
2349
DELISTED
Majesco
MJCO
| $829K | ﹤0.01% |
+136,332
| New | +$682K |
|
2350
Immunic
IMUX
$225M
| $823K | ﹤0.01% |
+473
| New | +$1.04M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.